Abivax SA
ABVXUnited States
9 filed reports · 297 financial concepts · 0 earnings calls · 2 media appearances
Filed reports
9 reports · Dec 2023 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 20 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Interim · 6-KSEC EDGAR | 5 | 1,418 | Mar 2025 to Jun 2026 |
| Annual · 20-FSEC EDGAR | 4 | 1,065 | Dec 2023 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Sep 21, 2026 | 57 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | May 22, 2026 | 478 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 23, 2026 | 20 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 23, 2026 | 1,015 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Dec 15, 2025 | 359 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Sep 8, 2025 | 316 | Open |
| FY2025 Q1 | 6-K | Mar 31, 2025 | Jun 2, 2025 | 208 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Mar 24, 2025 | 11 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Apr 5, 2024 | 19 | Open |
Financial data
297 concepts · 2,483 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial296 concepts · 2,471 facts · Sep 2022 to Jun 2026
- Advances related to CRO contracts18 · Dec 2023 to Mar 2026
- Convertible loan notes18 · Dec 2023 to Dec 2025
- EPS (Basic)16 · Dec 2022 to Jun 2026
- EPS (Diluted)16 · Dec 2022 to Jun 2026
- Interest Expense16 · Dec 2022 to Jun 2026
- Operating Income16 · Dec 2022 to Jun 2026
- R&D Expense16 · Dec 2022 to Jun 2026
- Income Tax Expense (Benefit)15 · Dec 2022 to Jun 2026
- Net Income15 · Dec 2022 to Jun 2026
- Other15 · Dec 2023 to Dec 2025
- Pretax Income15 · Dec 2022 to Jun 2026
- Cash and cash equivalents13 · Dec 2023 to Mar 2026
- Derivative financial liabilities (IFRS)13 · Dec 2023 to Mar 2026
- Equity13 · Dec 2023 to Mar 2026
- Financing Cash Flow13 · Dec 2022 to Jun 2026
- Intangible assets other than goodwill13 · Dec 2023 to Mar 2026
- Investing Cash Flow13 · Dec 2022 to Jun 2026
- Lease liabilities13 · Dec 2023 to Mar 2026
- Liabilities arising from financing activities13 · Dec 2023 to Mar 2026
- Number of shares issued13 · Dec 2023 to Mar 2026
- Operating Cash Flow13 · Dec 2022 to Jun 2026
- Property plant and equipment including rightofuse assets13 · Dec 2023 to Mar 2026
- Research tax credit ("CIR")13 · Dec 2023 to Mar 2026
- Adjustments for decrease increase in trade and other receivables12 · Dec 2023 to Mar 2026
Geography1 concepts · 12 facts · Dec 2023 to Mar 2026
- Average number of employees12 · Dec 2023 to Mar 2026
Segments
12 factsFigures broken down by business line, region, product or another axis the company reports on.
Geographical areas2 members · 12 facts
- FR6 · Dec 2023 to Mar 2026
- US6 · Dec 2023 to Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary39 claims from 2 reports · Dec 2024 to Dec 2025
- Risk-factor changes17 claims from 1 reports · Dec 2025
- Risk factors170 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
2 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances1 · Nov 2023
- Podcasts1 · Jan 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.